Blue Jet Healthcare Past Earnings Performance
Past criteria checks 4/6
Blue Jet Healthcare has been growing earnings at an average annual rate of 5.8%, while the Pharmaceuticals industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 12.6% per year. Blue Jet Healthcare's return on equity is 22.6%, and it has net margins of 23.5%.
Key information
5.8%
Earnings growth rate
5.8%
EPS growth rate
Pharmaceuticals Industry Growth | 17.5% |
Revenue growth rate | 12.6% |
Return on equity | 22.6% |
Net Margin | 23.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Blue Jet Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 7,449 | 1,748 | 503 | 0 |
30 Sep 23 | 7,471 | 1,802 | 484 | 0 |
30 Jun 23 | 7,560 | 1,763 | 454 | 0 |
31 Mar 23 | 7,210 | 1,600 | 419 | 0 |
31 Mar 22 | 6,835 | 1,816 | 330 | 0 |
31 Mar 21 | 4,989 | 1,384 | 290 | 0 |
31 Mar 20 | 5,382 | 1,448 | 239 | 0 |
Quality Earnings: BLUEJET has high quality earnings.
Growing Profit Margin: BLUEJET's current net profit margins (23.5%) are higher than last year (23.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BLUEJET's earnings have grown by 5.8% per year over the past 5 years.
Accelerating Growth: BLUEJET's earnings growth over the past year (5.7%) is below its 5-year average (5.8% per year).
Earnings vs Industry: BLUEJET earnings growth over the past year (5.7%) did not outperform the Pharmaceuticals industry 23.6%.
Return on Equity
High ROE: BLUEJET's Return on Equity (22.6%) is considered high.